(215 ILCS 5/513b1.1) (This Section may contain text from a Public Act with a delayed effective date) Sec. 513b1.1. Pharmacy benefit manager reporting requirements. (a) A pharmacy benefit manager that provides services for a health benefit plan must submit an annual report no later than September 1, to the Department, each health benefit plan sponsor, and each insurer that includes the following: (1) data on the health benefit plan including: (A) a list of drugs including corresponding |
| information on therapeutic class, brand name, generic name, or specialty drug name;
|
|
(B) number of covered individuals;
(C) number of drug-related claims;
(D) dosage units;
(E) dispensing channel used;
(F) average wholesale acquisition cost per drug;
|
|
(G) total out-of-pocket spending by deidentified
|
| covered individual per drug, per transaction;
|
|
(2) amount received by the health benefit plan in
|
| rebates, fees, or discounts related to drug utilization or spending;
|
|
(3) total gross spending on drugs by the health
|
|
(4) total net spending, gross spending less
|
| administrative portion of the medical loss ratio, on drugs by the health benefit plan;
|
|
(5) the amount paid by the health benefit plan to the
|
| pharmacy benefit manager for reimbursement cost of a drug and service per transaction;
|
|
(6) the amount a pharmacy benefit manager paid for
|
| pharmacists' services and drugs rendered related to the health benefit plan per transaction, including, but not limited to, any dispensing fee;
|
|
(7) the specific rebate amount received by the
|
| pharmacy benefit manager per transaction, the amount of the rebates passed through to the health benefit plan per transaction, and the amount of the rebates passed on to covered individuals at the point of sale that reduced the covered individuals' applicable deductible, copayment, coinsurance, or other cost-sharing amount per transaction;
|
|
(8) any information collected from drug manufacturers
|
| pertaining to copayment assistance to the extent such information is collected;
|
|
(9) any compensation paid to brokers, consultants,
|
| advisors, or any other individual or firm for referrals, consideration, or retention by the health benefit plan;
|
|
(10) explanation of benefit design parameters
|
| encouraging or requiring covered individuals to use affiliated pharmacies, percentage of drugs charged by these pharmacies, and a list of drugs dispensed by affiliated pharmacies with their associated costs; and
|
|
(11) a complete copy of each unredacted contract the
|
| pharmacy benefit manager has with the health benefit plan sponsor or insurer.
|
|
(b) Annual reports pursuant to subsection (a):
(1) must be written in plain language to ensure ease
|
| of reading and accessibility;
|
|
(2) must only contain summary health information to
|
| ensure plan, coverage, or covered individual information remains private and confidential;
|
|
(3) upon request by a covered individual, must be
|
| available in summary format and provide aggregated information to help covered individuals understand their health benefit plan's drug coverage; and
|
|
(4) must be filed with the Department no later than
|
| September 1 of each year via the Systems for Electronic Rates & Forms Filing (SERFF). The filing shall include the summary version of the report described in paragraph (3) of this subsection, which shall be marked for public access.
|
|
The Department may share all reports with an established institution of higher education in this State for the creation of a pharmacist dispensing cost report to be produced annually. This annual pharmacist dispensing cost report shall provide a survey of the average cost of dispensing a prescription for pharmacists in Illinois. The institution of higher education shall have the ability to request additional information from pharmacists for its analysis. The institution of higher education shall issue the report to the General Assembly no later than December 31, 2026 and annually thereafter.
(c) A pharmacy benefit manager may petition the Department for a filing submission extension. The Director may grant or deny the extension within 5 business days.
(d) Failure by a pharmacy benefit manager to submit all required elements in an annual report to the Department may result in a fine levied by the Director not to exceed $10,000 per day, per offense. Funds derived from fines levied shall be deposited into the Insurance Producer Administration Fund. Fine information shall be posted on the Department's website.
(e) A pharmacy benefit manager found in violation of subsection (a) or paragraph (4) of subsection (b) may request a hearing from the Director within 10 days of receipt of the Director's order, or, if the violation is found in a market conduct examination, as provided in Section 132 of this Code.
(f) Except for the summary version, the annual reports submitted by pharmacy benefit managers shall be considered confidential and privileged for all purposes, including for purposes of the Freedom of Information Act, shall not be subject to subpoena from any private party, and shall not be admissible as evidence in a civil action.
(g) A copy of an adverse decision against a pharmacy benefit manager for failing to submit an annual report to the Department must be posted to the Department's website.
(h) Nothing in this Section shall be construed as permitting a pharmacy benefit manager to avoid or otherwise fail to comply with the reporting requirements set forth in Section 5-36 of the Illinois Public Aid Code.
(Source: P.A. 104-27, eff. 1-1-26.)
|